Psychiatry AtlasMedication guide · United States

Antipsychotic medicine for specific difficult-to-treat conditions

Clozapine (Clozaril)

Generic name
clozapine
Brand names
Clozaril
Medication class
Antipsychotic medicine for specific difficult-to-treat conditions
Forms covered
oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

FDA Boxed Warning

oral tablets.

Boxed risks include severe neutropenia with potentially fatal infection; low blood pressure, slow heart rate and fainting; seizures; myocarditis, pericarditis and cardiomyopathy; and increased death risk in older adults with dementia-related psychosis. Clozapine is not approved for dementia-related psychosis. Blood-count monitoring and careful initiation or restart remain essential.

Clozapine treats schizophrenia that has not responded adequately to standard antipsychotics. It also reduces recurrent suicidal behavior in selected people with schizophrenia or schizoaffective disorder, with close monitoring for serious risks.

What to expect: Full benefit may take several weeks or longer, and the medicine is introduced gradually for safety.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Treatment-resistant schizophrenia — Adults with severe schizophrenia and inadequate response to standard antipsychotic treatment. The label reserves this use because of serious risks including severe neutropenia and seizures.oral tablets.
  • Reduction of recurrent suicidal behavior — Adults with schizophrenia or schizoaffective disorder at chronic risk based on history and current state. This is a specific risk-reduction indication, not an emergency rescue treatment or approval for all causes of suicidal thoughts.oral tablets.

What should I expect?

Full benefit may take several weeks or longer, and the medicine is introduced gradually for safety. Agree with the care team on the symptoms and day-to-day changes to track, alongside blood tests, bowel function, and physical health.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Take the exact prescribed tablets with or without food. Follow the gradual starting plan because low blood pressure, slow pulse, and fainting can occur, particularly when starting or restarting. Do not increase the dose yourself.

An absolute neutrophil count (ANC) is needed before treatment and regularly afterward. For usual normal counts, the label recommends weekly testing for six months, every two weeks in months 7–12, and monthly afterward; low counts or interruptions change the plan. Your team interprets the results and any individualized pathway.

Monitor bowel function actively and keep the care team’s plan for constipation. Blood pressure, pulse, weight, glucose, blood fats, and symptoms of heart inflammation also need review. Avoid driving or hazardous work until you know how it affects you.

Do not use after hypersensitivity to clozapine or a product ingredient.

Strong CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin can markedly raise clozapine concentrations and require substantial prescriber dose changes. Strong CYP3A4 inducers are generally not recommended. Stopping tobacco smoking can raise exposure; changes in smoking or caffeine intake should be discussed.

Other anticholinergic medicines and drugs that slow bowel activity increase the risk of severe constipation complications. Sedatives and blood-pressure medicines can add to impairment or hypotension; other drugs causing neutropenia may require closer ANC monitoring.

Discuss pregnancy and the risks of untreated illness with the prescribing team. Third-trimester antipsychotic exposure can cause neonatal movement, feeding, breathing or withdrawal symptoms. Clozapine enters breast milk; reported infant adverse effects include sedation and severe neutrophil reduction, so breastfeeding requires particular specialist discussion and infant monitoring if exposure occurs.

Safety and effectiveness in children are not established by this label. Older adults may be especially sensitive to low blood pressure, fast heartbeat, constipation and urinary retention. Significant kidney or liver impairment may warrant a lower dose.

Contact the prescriber after a missed day or other interruption before restarting. The current Clozaril label requires reduced restarting doses even after one or two missed days; longer interruptions restart at a very low dose. Do not double doses or resume the previous full dose yourself.

Planned discontinuation usually uses a clinician-supervised reduction, while urgent medical problems may require immediate interruption. Abrupt stopping can cause recurrence of psychosis and cholinergic rebound, including sweating, headache, nausea, vomiting or diarrhea. Blood monitoring may still be needed after stopping.

What side effects should I know about?

  • Sleepiness, dizziness, excess saliva, fast heartbeat, constipation, nausea and weight gain.
  • Dry mouth, sweating, tremor and visual disturbance may occur; fever must be evaluated rather than dismissed as routine.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Fever, sore throat, mouth sores or other infection symptoms require urgent medical contact because severe neutropenia can develop.
  • Chest pain, breathlessness, persistent fast heartbeat, fainting, swelling or unexplained severe fatigue may signal myocarditis, cardiomyopathy or another serious problem.
  • Contact the care team promptly about new or worsening constipation. Abdominal pain or swelling, vomiting, or inability to pass stool or gas requires urgent medical assessment; severe symptoms need emergency care because bowel complications can be fatal.
  • Seek emergency care for high fever with severe stiffness or confusion, trouble breathing, collapse, a seizure, or a suspected overdose. New involuntary movements, severe restlessness, or symptoms of high blood sugar need prompt medical assessment.
  • Yellow skin or eyes, dark urine, or other signs of liver illness need prompt medical assessment. Sudden chest pain or breathlessness can also signal a blood clot and needs emergency care.

What else should I know to stay safe?

  • Clozapine requires a baseline absolute neutrophil count (ANC) and continuing blood tests. The usual schedule with normal counts is weekly for six months, every two weeks in months 7–12, and monthly afterward; low counts or interruptions change the plan. Removal of REMS paperwork did not remove monitoring.
  • Follow the gradual starting plan. Contact the prescriber after a missed day or another interruption before restarting; the previous full dose can cause severe low blood pressure or fainting. Plan stopping with the care team because abrupt withdrawal can cause returning symptoms and physical withdrawal effects; blood monitoring may still be needed afterward.
  • Monitor bowel function actively, along with blood pressure, pulse, weight, glucose, blood fats, and cardiac symptoms. Do not use after a clozapine allergy. Review kidney or liver problems, urinary retention, and medicines that worsen constipation, lower white cells, or add sedation or low blood pressure.
  • Fluvoxamine, ciprofloxacin, some seizure medicines, and other interacting drugs can greatly change clozapine levels. Changes in tobacco smoking or caffeine intake also matter; have them reviewed before altering your routine.
  • Discuss pregnancy and breastfeeding with specialists. Later-pregnancy exposure can affect a newborn’s movement, breathing, or feeding. Clozapine enters milk and serious infant effects have been reported. Children’s safety and effectiveness are not established by this label; older adults may be particularly sensitive to bowel and blood-pressure effects.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Constipation deserves active attention, even when it seems mild. Clozapine can slow the bowel dangerously, so a bowel-monitoring plan is part of treatment.
  • A missed day changes the restart question. Contact the prescriber before resuming: restarting the previous full dose after an interruption can cause severe low blood pressure or fainting.
  • Removal of REMS paperwork did not remove blood-test monitoring. Follow the current plan for the absolute neutrophil count, which measures infection-fighting white cells.

How does it work?

Clozapine affects several systems that brain cells use to communicate. It acts at receptors, the proteins that respond to chemical messengers such as dopamine and serotonin. Researchers have identified many of these actions, but no single one fully explains why clozapine can help when other treatments have not.

Explore medication science

How was this medicine developed?

Clozaril received FDA approval in 1989 and became an option for schizophrenia that had not responded adequately to other antipsychotics. FDA removed the U.S. clozapine REMS enrollment and reporting program in June 2025; the serious blood-cell risk and recommended blood monitoring remain.

How do I say the name?

Clozapine: KLOH-zuh-peen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Clozaril oral tablets: FDA-approved prescribing information (PDF)
  2. MedlinePlus: clozapine
  3. Drugs@FDA: Clozaril approval and regulatory history
  4. FDA removes clozapine REMS; ANC monitoring remains necessary
  5. Clozaril: current US prescribing information (6/2025)
  6. Clozapine: Package Insert / Prescribing Information / MOA
  7. DailyMed - CLOZAPINE tablet
  8. What Is a Neurotransmitter?
  9. PubChem: clozapine, CID 135398737
  10. FDA: Seroquel immediate-release label and Medication Guide
  11. ISMP List of Confused Drug Names
  12. NIMH: Understanding psychosis

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top